| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 1,600 | ₹1,26,400 |
| HNI / NII | 2 | 3,200 | ₹2,52,800 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 21,47,200 (41.70%) | — | — |
| NII / HNI (Total) | — | 6,44,800 (12.52%) | — | — |
| Retail Investors | — | 15,04,000 (29.21%) | — | — |
| Market Maker * | 1× | 8,52,800 (16.56%) | 8,52,800 (16.56%) | ₹673.71 Cr |
| Total ** | — | 51,48,800 (100.00%) | — | — |
| Metric | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Revenue | 6948.43 | 11569.65 | 9266.63 |
| PAT | 539.38 | 515.29 | 312.86 |
| EBITDA | — | — | — |
| Net Worth | 2264.96 | 1724.42 | 1209.09 |
| Total Assets | 11249.04 | 9793.83 | 6858.47 |
| Reserves | 1064.96 | 1684.42 | 1169.09 |
| Borrowings | 2902.81 | 2605.03 | 1880.86 |
Incorporated in 2000, Zenith Drugs Limited is a pharmaceutical company specialising in manufacturing and trading high-quality, affordable medicines, including generic drugs.
The company adheres to WHO-GMP guidelines and has received the ISO 9001:2015 certification from a respected EuroUK certification body, demonstrating its commitment to quality.
The product portfolio of the company includes
The Food & Drugs Administration has approved over 600 products, of which 325 are currently in production.
The company is in the process of setting up a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.
The company supplies its products to countries such as Costa Rica in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan , Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.
Zenith Drugs Limited specializes in third-party manufacturing, also known as white label manufacturing, for esteemed pharmaceutical companies such as Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.
There are currently 89 employees as of March 31, 2023 - 61 on payroll and 28 on contract.